6 completed, 2 recruiting, 2 unknown. 10 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Recruiting 2, Unknown 2 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow nabilone: new trials by email Literature Review of nabilone trials Research Report on nabilone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder PP-01, Nabilone, Placebo - Cannabis Withdrawal | Phase 3 | Recruiting | PleoPharma, Inc. | 420 | 2026-06-17 | 2026-10-27 |
| Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury Placebo diet, Anti-inflammatory diet, Nabilone Capsules - Spinal Cord Injuries, Neuropathic Pain | Phase 3 | Completed | Eldon Loh, MD | 14 | 2023-03-01 | 2025-07-22 |
| DIalysis Symptom COntrol-Pruritus Outcome Trial Nabilone 0.5 MG Oral Capsule, Placebo Nabilone - End Stage Renal Disease, Pruritus | Phase 3 | Completed | University of Manitoba | 14 | 2022-08-02 | 2023-11-30 |
| Nabilone for Agitation Blinded Intervention Trial Nabilone, Placebo - Alzheimer Disease, Agitation | Phase 3 | Recruiting | Sunnybrook Health Sciences Centre | 112 | 2021-02-01 | 2026-11-06 |
| Nabilone for Non-motor Symptoms in Parkinson's Disease Nabilone 0.25 mg - Parkinson Disease | Phase 3 | Completed | Medical University Innsbruck | 22 | 2018-08-06 | 2021-03-02 |
| Safety and Efficacy of Nabilone in Alzheimer's Disease Nabilone, Placebo - Alzheimer Disease, Agitation | Phase 2 / Phase 3 | Completed | Sunnybrook Health Sciences Centre | 38 | 2015-01-01 | 2020-06-25 |
| Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients Nabilone, Placebo - Non-Small Cell Lung Cancer, Anorexia | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Cancerologia de Mexico | 78 | 2014-12-01 | 2016-08-31 |
| Nabilone for Cannabis Dependence: A Pilot Study Nabilone, Placebo - Cannabis Dependence, Marijuana Dependence | Phase 2 / Phase 3 | Completed | Mclean Hospital | 84 | 2010-06-01 | 2018-06-01 |
| Nabilone & Marijuana Addiction Cesemat - Marijuana Smoking | Phase 2 / Phase 3 | Completed | University of British Columbia | 35 | 2009-06-01 | 2011-02-17 |
| Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain Nabilone, flexible dosing - Diabetic Neuropathies | Phase 3 | Unknown | University of Calgary | 60 | 2008-01-01 | 2009-12-18 |
Marijuana Abuse (3) · Alzheimer Disease (2) · Neuralgia (2) · Pain (2) · Psychomotor Agitation (2) · Anorexia (1) · Cachexia (1) · Carcinoma, Non-Small-Cell Lung (1) · Diabetic Neuropathies (1) · Kidney Failure, Chronic (1) · Marijuana Smoking (1) · Parkinson Disease (1) · Pruritus (1) · Spinal Cord Injuries (1) · Weight Loss (1)
Sunnybrook Health Sciences Centre (2) · Eldon Loh, MD (1) · Instituto Nacional de Cancerologia de Mexico (1) · Mclean Hospital (1) · Medical University Innsbruck (1) · PleoPharma, Inc. (1) · University of British Columbia (1) · University of Calgary (1) · University of Manitoba (1)
Canada (6) · United States (2) · Austria (1) · Mexico (1)
Cory Toth, MD (1) · David Collister, MD, PhD (1) · David Ditor, MD (1) · Eldon Loh, MD (1) · Giovanni Marotta, MD (1) · Jay Constantine, MD (1) · Kevin P Hill, MD, MHS (1) · Krista L. Lanctot, PhD (1) · Nathan Herrmann, MD (1) · Oscar Arrieta, MD M Sc (1) · Shaohua Lu, MD (1)
PMID 11786587, PMID 12457271, PMID 15778874, PMID 15857739, PMID 16376734, PMID 16408219, PMID 1666930, PMID 16849753, PMID 17589370, PMID 18402303, PMID 21343383, PMID 29550881, PMID 30753761, PMID 31182351, PMID 31322567, PMID 31547752, PMID 34532852, PMID 3774823, PMID 8035251, PMID 8558188
K99DA029115 (1), U01DA066079 (1)